Applied Therapeutics (APLT) P/FCF US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -6.18 | -2.53 | -0.37 | -5.12 | -1.42 | -1.01 | |||
| Changes by years, y/y, % | -36% | -59% | -85% | +1 290% | -72% | -31.9% | |||
Applied Therapeutics. P/FCF
Applied Therapeutics. P/FCF, changes, %
Applied Therapeutics (APLT) P/FCF US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | LTM ? | |||
| P/FCF | -15.0 | -1.27 | -0.75 | -0.49 | -1.01 | -1.01 | ||
| Changes by years, y/y, % | +259% | -75% | -94% | -95% | -93% | |||
| Changes by quarters, q/q, % | +63% | -92% | -41% | -35% | +106% | |||